Durham, NC, United States of America

Joseph Wendell Wilson

USPTO Granted Patents = 7 


Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2000-2011

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Joseph Wendell Wilson: Innovator in Pharmaceutical Chemistry

Introduction

Joseph Wendell Wilson is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on developing innovative compounds for medical applications, particularly in cancer treatment.

Latest Patents

Among his latest patents, Wilson has developed compounds such as 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives, which serve as IGF-1R inhibitors for cancer treatment. These novel pyrrolopyrimidines are designed to inhibit IGF-1R effectively. Additionally, he has patented 2-pyrimidinyl pyrazolopyridine compounds, which are ErbB kinase inhibitors. These compounds and their compositions are intended for use as pharmaceutical agents, showcasing Wilson's commitment to advancing medical science.

Career Highlights

Throughout his career, Wilson has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and GlaxoSmithKline LLC. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations

Wilson has collaborated with notable colleagues such as Sean Patrick Hollinshead and Philip Floyd Hughes. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work in the field.

Conclusion

Joseph Wendell Wilson is a distinguished inventor whose contributions to pharmaceutical chemistry have the potential to transform cancer treatment. His innovative patents and collaborations reflect his dedication to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…